79691-74-0 Usage
Description
5-Pyrimidinemethanol, alpha-methyl(9CI) is a pyrimidine derivative, which is an organic compound characterized by the presence of a pyrimidine ring. This specific compound features a methyl group attached to the alpha position, which is the carbon atom adjacent to the hydroxymethyl group. Its unique structure and properties make it a valuable component in the development of pharmaceuticals and other applications.
Uses
Used in Pharmaceutical Industry:
5-Pyrimidinemethanol, alpha-methyl(9CI) is used as a key intermediate in the synthesis of muscarinic agonists for the treatment of Alzheimer's disease. As a pyrimidine derivative, it plays a crucial role in the development of these drugs, which aim to improve cognitive function and memory in patients suffering from this neurodegenerative disorder.
Check Digit Verification of cas no
The CAS Registry Mumber 79691-74-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,6,9 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 79691-74:
(7*7)+(6*9)+(5*6)+(4*9)+(3*1)+(2*7)+(1*4)=190
190 % 10 = 0
So 79691-74-0 is a valid CAS Registry Number.
79691-74-0Relevant articles and documents
cGAS ANTAGONIST COMPOUNDS
-
Paragraph 0275, (2017/11/06)
Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
Pyridocarbazole derivatives having cGMP-PDE inhibitory activity
-
, (2008/06/13)
PCT No. PCT/JP97/01829 Sec. 371 Date Jan. 29, 1998 Sec. 102(e) Date Jan. 29, 1998 PCT Filed May 29, 1997 PCT Pub. No. WO97/45427 PCT Pub. Date Dec. 4, 1997The invention relates to novel pyridocarbazole derivatives having highly selective action in inhibiting cyclic GMP-phosphodiesterase (hereinafter abbreviated as cGMP-PDE), processes for producing such derivatives, agents containing at least one of such derivatives as an active ingredient for preventing and/or treating pulmonary hypertension, ischemic heart diseases or diseases against which the cGMP-PDE inhibitory action is effective, and intermediates useful for the production of pyridocarbazole derivatives.
